Boudousquie et al. reported the IMCgp100, an ImmTAC recognizing a peptide derived from the melanoma-specific protein, gp100, efficiently redirects and activates effector and memory cells from both CD8+ and CD4+ T cells. The gene discussed is CD4; the disease is melanoma.